Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Atomo Diagnostics has raised $1.6M in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Atomo Diagnostics's investors include Bill & Melinda Gates Foundation, Department of Industry, Innovation and Science, Grand Challenges Canada, Sydney Angels, Global Health Investment Fund (GHIF).
Atomo Diagnostics is headquartered in Leichhardt, Australia.
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Atomo Diagnostics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atomo Diagnostics — Funding & Investors." VCBacked, October 22, 2024, https://www.vcbacked.co/company/atomo-diagnostics. Accessed August 21, 2026.
VCBacked. (2024). Atomo Diagnostics — Funding & Investors. Retrieved August 21, 2026, from https://www.vcbacked.co/company/atomo-diagnostics
{{cite web |title=Atomo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/atomo-diagnostics |website=VCBacked |access-date=August 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated